$18.68
-0.31-1.63%
At Close: -
$18.68
00.00%
After Hours: 4:04 PM EDT
15 minutes delayed
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
The most recent guidance for Medifast (MED) was reported on August 5, 2024 for Q3 2024. The company provided earnings per share guidance in the range of $-0.70 to $-0.05, compared to the estimated EPS of $-0.52. Additionally, Medifast forecasted revenue between $0.13B and $0.14B for the quarter.
Browse guidance and forecast on all stocks.